28 January 2019
Researchers at the University of Edinburgh’s Roslin Institute in the UK have genetically modified chickens that can lay eggs containing human proteins, which could be used as drugs.
7 December 2018
After two years of planning, UK-based pharmaceutical company Mallinckrodt has announced plans to split its speciality generics and active pharmaceutical ingredients (APIs) business, in addition to the drug amitiza (lubiprostone),...
29 November 2018
CVS Health has completed its previously announced acquisition of all outstanding shares of healthcare benefits provider Aetna in a deal valued at $69bn.
30 October 2018
Scotland's pharmaceutical sector is worth £1.7bn (gross value added) to the country’s economy, according to a report by the Fraser of Allander Institute at the University of Strathclyde.
29 October 2018
Johnson & Johnson has unveiled a new vaccines launch facility in Leiden, the Netherlands for supporting the development and roll out of new vaccines on a mass scale for public...
17 October 2018
Swiss pharma company Roche reported 7% year on year increase in sales to CHF42.1bn ($42.5bn) in the first nine months of 2018 as newly launched drugs offset the impact of...
16 October 2018
Anglo-Swedish biopharma company AstraZeneca’s non-executive chairman Leif Johansson has unveiled to French newspaper La Monde that the company will continue its freeze on manufacturing investments in Britain if uncertainty over...
3 October 2018
Researchers at the University of Pennsylvania’s Abramson Cancer Centre have reported that the accidental genetic engineering of a single leukemic cell during the early manufacturing of CAR-T therapy tisagenlecleucel, which...
28 September 2018
Swiss pharmaceutical company Novartis has signed an exclusive marketing agreement with Cellular Biomedicines to manufacture its CAR-T therapy Kymriah in China.
20 September 2018
In this issue: Making manufacturing work in gene and cell therapies, AI generated compounds, clinical trial transparency in the Americas, and more.